Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: And some still think S&L is our enemy....

Or to clarify, the 10-Q may have come out April 20th, but the sentence in the 10-Q reads.........

As of February 28, 2007, we had warrants outstanding to purchase 29,906,015 common shares at exercise prices ranging from $0.02 to $1.00 per share, expiring at various dates through 2012.

Thing is, this is an accelerated pace of conversions when looking at prior qtrs. and I just don't get why?..........

Share
New Message
Please login to post a reply